Literature DB >> 21095172

Two new protocols to enhance the production and isolation of human induced pluripotent stem cell lines.

Emily Dick1, Elena Matsa, Jayson Bispham, Mojgan Reza, Michela Guglieri, Andrew Staniforth, Sue Watson, Rajendra Kumari, Hanns Lochmüller, Lorraine Young, David Darling, Chris Denning.   

Abstract

There are two critical stages in the retroviral reprogramming of somatic cells to produce human induced pluripotent stem cell (hiPSC) lines. One is the production of high titer virus required to reprogram somatic cells; the other is identification of true hiPSC colonies from heterogeneous cell populations, and their isolation and expansion to generate a sustainable, pluripotent stem cell line. Here we describe simple, time-saving methods to address the current difficulties at these two critical junctures. First, we have developed a method to increase the number of infectious viral units 600-fold. Second, we have developed a TRA-1-81-based positive selection column method for isolating "true" hiPSCs from the heterogeneous cell populations, which overcomes the labor-intensive and highly subjective method of manual selection of hiPSC colonies. We have used these techniques to produce 8 hiPSC lines from human fibroblasts and we believe that they are of considerable utility to researchers in the hiPSC field.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21095172     DOI: 10.1016/j.scr.2010.10.002

Source DB:  PubMed          Journal:  Stem Cell Res        ISSN: 1873-5061            Impact factor:   2.020


  12 in total

Review 1.  Science and ethics: bridge to the future for regenerative medicine.

Authors:  Ventura-Juncá Patricio
Journal:  Int J Stem Cells       Date:  2011-11       Impact factor: 2.500

2.  Faster generation of hiPSCs by coupling high-titer lentivirus and column-based positive selection.

Authors:  Emily Dick; Elena Matsa; Lorraine E Young; David Darling; Chris Denning
Journal:  Nat Protoc       Date:  2011-05-05       Impact factor: 13.491

3.  Selecting and isolating colonies of human induced pluripotent stem cells reprogrammed from adult fibroblasts.

Authors:  Urszula Polak; Calley Hirsch; Sherman Ku; Joel Gottesfeld; Sharon Y R Dent; Marek Napierala
Journal:  J Vis Exp       Date:  2012-02-20       Impact factor: 1.355

Review 4.  In vitro uses of human pluripotent stem cell-derived cardiomyocytes.

Authors:  Elena Matsa; Chris Denning
Journal:  J Cardiovasc Transl Res       Date:  2012-05-26       Impact factor: 4.132

5.  Exon skipping and gene transfer restore dystrophin expression in human induced pluripotent stem cells-cardiomyocytes harboring DMD mutations.

Authors:  Emily Dick; Spandan Kalra; David Anderson; Vinoj George; Morten Ritso; Steven H Laval; Rita Barresi; Annemieke Aartsma-Rus; Hanns Lochmüller; Chris Denning
Journal:  Stem Cells Dev       Date:  2013-07-05       Impact factor: 3.272

6.  Drug evaluation in cardiomyocytes derived from human induced pluripotent stem cells carrying a long QT syndrome type 2 mutation.

Authors:  Elena Matsa; Divya Rajamohan; Emily Dick; Lorraine Young; Ian Mellor; Andrew Staniforth; Chris Denning
Journal:  Eur Heart J       Date:  2011-03-02       Impact factor: 29.983

7.  The EuroBioBank Network: 10 years of hands-on experience of collaborative, transnational biobanking for rare diseases.

Authors:  Marina Mora; Corrado Angelini; Fabrizia Bignami; Anne-Mary Bodin; Marco Crimi; Jeanne-Hélène Di Donato; Alex Felice; Cécile Jaeger; Veronika Karcagi; Yann LeCam; Stephen Lynn; Marija Meznaric; Maurizio Moggio; Lucia Monaco; Luisa Politano; Manuel Posada de la Paz; Safaa Saker; Peter Schneiderat; Monica Ensini; Barbara Garavaglia; David Gurwitz; Diana Johnson; Francesco Muntoni; Jack Puymirat; Mojgan Reza; Thomas Voit; Chiara Baldo; Franca Dagna Bricarelli; Stefano Goldwurm; Giuseppe Merla; Elena Pegoraro; Alessandra Renieri; Kurt Zatloukal; Mirella Filocamo; Hanns Lochmüller
Journal:  Eur J Hum Genet       Date:  2014-12-24       Impact factor: 4.246

8.  FAS-based cell depletion facilitates the selective isolation of mouse induced pluripotent stem cells.

Authors:  Eva Warlich; Axel Schambach; Dominik Lock; Dirk Wedekind; Silke Glage; Dominik Eckardt; Andreas Bosio; Sebastian Knöbel
Journal:  PLoS One       Date:  2014-07-16       Impact factor: 3.240

9.  Allele-specific RNA interference rescues the long-QT syndrome phenotype in human-induced pluripotency stem cell cardiomyocytes.

Authors:  Elena Matsa; James E Dixon; Christopher Medway; Orestis Georgiou; Minal J Patel; Kevin Morgan; Paul J Kemp; Andrew Staniforth; Ian Mellor; Chris Denning
Journal:  Eur Heart J       Date:  2013-03-06       Impact factor: 29.983

Review 10.  Current status of drug screening and disease modelling in human pluripotent stem cells.

Authors:  Divya Rajamohan; Elena Matsa; Spandan Kalra; James Crutchley; Asha Patel; Vinoj George; Chris Denning
Journal:  Bioessays       Date:  2012-08-08       Impact factor: 4.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.